MedTrace Logo

Feasibility Study of MicroKine Dx System in Critically-ill Pediatric Patients.

NCT04295278 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2020-09-16

No results posted yet for this study

Summary

This study will enroll approximately 25 pediatric patients to assess the performance and real-world feasibility of multi-biomarker based prognostic and predictive algorithms to aid in the clinical management of pediatric critically-ill patients.

Conditions

  • Multiple Organ Failure

Interventions

DIAGNOSTIC_TEST

MicroKine Dx system

Biomarker concentrations will be determined using the MicroKine Dx system and results will be compared to measurements taken using standard immunoassays.

Sponsors & Collaborators

  • PreDxion Bio, Inc.

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Information · PreDxion Bio, Inc.

Eligibility

Min Age
38 Weeks
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-12-31
Completion
2022-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295278 on ClinicalTrials.gov